C07F 9 - Compounds containing elements of the 5th group of the periodic system

Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
11/2006
11/30/2006	CA2606497A1 Novel phosphorus-containing thyromimetics
11/29/2006	EP1726595A1 Crystalline form of fosinopril calcium
11/29/2006	EP1726594A1 Salts comprising cynoborate anions
11/29/2006	EP1726593A1 Salts comprising cyanoborate anions
11/29/2006	EP1726580A1 Aminophenylpropanoic acid derivative
11/29/2006	EP1725570A1 Process for the production of asymmetric transformation catalysts
11/29/2006	EP1725569A1 Prodrugs of piperazine and substituted piperidine antiviral agents
11/29/2006	EP1656385B1 Perfluoropolyether amide-linked phosphonates, phosphates, and derivatives thereof
11/29/2006	EP0971854B1 Novel materials useful as electrolytic solutes
11/29/2006	CN1871246A Methods for the preparation of {2-[(8,9)-dioxo-2,6-diaza-bicyclo[5.2.0]-non-1(7)-en-2-yl[ethyl} phosphonic acid and esters thereof
11/29/2006	CN1871245A Process for the preparation of N-phosphonomethylglycine and derivatives thereof
11/29/2006	CN1871233A Novel chelating agents and chelates and their use
11/29/2006	CN1869041A Synthesis method of phenyl dioster diphosphate
11/29/2006	CN1869040A Preparation method of food grade concentrated rape phospholipid
11/29/2006	CN1869039A Preparation method of halogenated alkyldiphenyl sulfonium hexafluoro phosphate and application
11/29/2006	CN1286844C Medicinal composition containing angiotensin II receptor antagonist and vitamin B
11/28/2006	US7141684 Such as 2,6-di-(2,3-epoxypropyl)phenyl methyl ether; intermediates for production of epoxy resins
11/28/2006	US7141672 Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
11/28/2006	US7141655 Reagents and procedures for high-specificity labeling
11/28/2006	US7141588 N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
11/28/2006	US7141557 Lipid analogs for treating viral infections
11/28/2006	US7141552 Use of lipid conjugates in the treatment of diseases
11/23/2006	WO2006125130A1 Methods for synthesizing heterocyclic compounds
11/23/2006	WO2006124686A2 Modulation of stat 6 expression for the treatment of airway hyperresponsiveness
11/23/2006	WO2006123254A2 Method for determining phytase activity
11/23/2006	WO2006122444A1 Preparation method of chloramine phosphorus
11/23/2006	WO2005102997A8 3,4-disubstituted maleimides for use as vascular damaging agents
11/23/2006	US20060264673 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
11/23/2006	US20060264655 dissolving or suspending in water in presence of base, neutralizing with acid forming precipitate
11/23/2006	US20060264654 Method for the production of cyclic phosphonic acid anhydrides
11/23/2006	US20060264645 Phosphonium and imidazolium salts and methods of their preparation
11/23/2006	US20060264642 Mixtures of ionic liquids with lewis acids
11/23/2006	US20060264492 methyl [5(6)-(4-alanylaminophenylthio)-1H-benzimidazol-2yl]carbamate; for treating neovascularization, solid tumors, macular degeneration, diabetic retinopathy, rheumatoid arthritis, psoriasis, and atherosclerosis
11/23/2006	US20060264456 Phosphorus-containing compounds & uses thereof
11/23/2006	US20060264407 Useful as cosmetics and quasi drugs; L-ascorbic acid-2-phosphate ester
11/23/2006	US20060264406 Mono-lysine salts of azole compounds
11/23/2006	US20060264405 Dimethylphosphinorapamycin; treating cancer; improved therapeutic index, pharmacokinetics, and formulatability
11/23/2006	US20060264404 Therapeutic phosphonate compounds
11/23/2006	US20060264403 phosphoric acid mono-[2-hydroxymethyl-4-(4-octyl-phenyl)-2-(1-oxo-1,3-dihydro-isoindol-2-yl)-butyl] ester; disorders mediated by lymphocytes interactions like transplant rejection, graft versus host disease, autoimmune diseases; binding affinity to Sphingosine-1-phosphate(S1P) receptors
11/23/2006	US20060264397 Compositions and methods for targeting cancer cells
11/23/2006	US20060263696 Additive for non-aqueous electrolyte and secondary battery using the same
11/23/2006	US20060263435 nucleic acid such as siRNAs; carrier includes a cyclodextrin polymer; treatment of cell proliferative disorders, such as cancer or pathogen infections
11/23/2006	DE102005022843A1 Phosphor-haltige Monomere, Verfahren zu ihrer Herstellung sowie deren Verwendung Phosphorus-containing monomers, processes for their preparation and their use
11/23/2006	CA2600689A1 Method for determining phytase activity
11/22/2006	EP1724276A1 Novel phosphorus-containing prodrugs
11/22/2006	EP1724275A1 Process for producing aminophosphonic acid derivative
11/22/2006	EP1723157A1 Amorphous forms of risedronate monosodium
11/22/2006	EP1723156A1 Process for the preparation of pyridine derivatives
11/22/2006	EP1723155A1 Phosphoric acid esters and their use as wetting and dispersing agent
11/22/2006	EP1723154A2 Isotopically-enriched boranes and methods of preparing them
11/22/2006	EP1723121A1 1,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors
11/22/2006	EP1723118A2 Method for the production of ionic fluids the cation of which comprises a quaternary sp2 - hybridised nitrogen atom
11/22/2006	EP1506309B1 Plating media
11/22/2006	EP1362877B1 One-pack moisture-curing epoxy resin composition
11/22/2006	CN2839281Y Crystalline triphenyl phosphate
11/22/2006	CN1867580A Compound modified with glycerol derivative
11/22/2006	CN1867404A Transition metal-carbide and nitride containing catalysts, their preparation and use as oxidation and dehydrogenation catalysts
11/22/2006	CN1865268A Method for producing glyphosate monovalent salt using glyphosate bivalent, trivalent salt
11/22/2006	CN1285657C Polymer flame retardant of containing two different aryl phosphates mixture, method for preparing same and use thereof
11/22/2006	CN1285600C Glyphosate preparation and method for preparing same
11/22/2006	CN1285277C Production of powdery lipoid
11/21/2006	US7138552 precursor for the preparation of compounds having surfactant properties and of plasticizers
11/21/2006	US7138547 Antitumoral compounds
11/21/2006	US7138530 for inhibiting the enzyme C1s, a protease in the classical pathway of the complement system; and the use of this inhibition to treat or ameliorate acute or chronic disorders in mammals
11/21/2006	US7138503 Synthetic molecules that specifically react with target sequences
11/21/2006	US7138445 Flame retardant thermoplastic resin composition
11/21/2006	US7138402 Pyrrolopyrimidines and related analogs as HSP90-inhibitors
11/21/2006	US7138401 9-(Substituted phenyl or pyridyl)methyl-2-amino-6-halopurines, e.g., 6-chloro-9-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethyl)-9H-purin-2-ylamine; used in the treatment and prevention of various Heat Shock Protein 90 mediated disorders, e.g., proliferative disorders
11/21/2006	US7138356 Alkoxylated phosphite ester and process therefor
11/21/2006	CA2084017C Metallocenes having benzo-fused indenyl derivatives as ligands, processes for their preparation and their use as catalysts
11/16/2006	WO2006121951A2 Antisense antiviral compounds and methods for treating foot and mouth disease
11/16/2006	WO2006121058A1 Organometallic compound, catalyst for polymerization of polar group-containing norbornene and process for producing norbornene polymer
11/16/2006	WO2006121035A1 Process for producing organic compound labeled with radioactive halogen
11/16/2006	WO2006121019A1 Vanadium complex
11/16/2006	WO2006119713A2 Antineoplastic compounds and pharmaceutical compositions thereof
11/16/2006	WO2006076415A3 Exo- and diastereo- selective syntheses of himbacine analogs
11/16/2006	US20060258822 Curing accelerator, epoxy resin composition, and semiconductor device
11/16/2006	US20060258737 Resistance-repellent retroviral protease inhibitors
11/16/2006	US20060258641 Methods and compositions of novel triazine compounds
11/16/2006	US20060258625 Process for the preparation of biphosphonic derivatives
11/16/2006	US20060258616 Natural semi-synthetic and synthetic lipid derivatives of ceramide and sphingosine groups, drugs and the medical use thereof in the form of therapeutic agents in particular for dermatology
11/16/2006	US20060258612 CFTR channel modulators
11/16/2006	US20060258610 Modulation of STAT 6 expression for the treatment of airway hyperresponsiveness
11/16/2006	US20060257681 Strongly adherent surface coatings
11/16/2006	CA2607298A1 Antineoplastic compounds and pharmaceutical compositions thereof
11/15/2006	EP1412383B1 Peptide conjugates, their derivatives with metal complexes and use thereof for magnetic resonance imaging (mri)
11/15/2006	EP1244679B1 Purine derivatives
11/15/2006	EP0931078B1 Novel tricyclic piperidinyl compounds useful as inhibitors of farnesyl-protein transferase
11/15/2006	CN1864434A Wireless microphone communication system
11/15/2006	CN1863826A Process for the preparation of a metalloorganic compound comprising at least one imine ligand
11/15/2006	CN1863825A Process for the preparation of a metalloorganic compound comprising at least one imine ligand
11/15/2006	CN1863824A Process for the preparation of a metalloorganic compound comprising at least one imine ligand
11/15/2006	CN1863823A Process for the preparation of a metalloorganic compound comprising at least one imine ligand
11/15/2006	CN1863810A Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and methods of use thereof
11/15/2006	CN1863809A Ligands for pnicogen chelate complexes with a metal of subgroup viii and use of the complexes as catalysts for hydroformylation, carbonylation, hydrocyanation or hydrogenation
11/15/2006	CN1863797A Cyclic amine BACE-1 inhibitors having a benzamide substituent
11/15/2006	CN1861619A Cobait dipenta cation diphosphine ligand preparation and application thereof
11/15/2006	CN1861614A Preparation process of isocyclo phosphamide
11/15/2006	CN1861613A Preparation process and use of2-chloro ethyl zinc phosphonate
11/15/2006	CN1861612A Production process of solid alkylphosphonate

1 ... 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 ... 554